Identification of candidate plasma miRNA biomarkers for the diagnosis of head and neck squamous cell carcinoma

References

• Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Prim. 6(1), 92 (2020).
   PubMed Web of Science ®Google Scholar
• Zaporozhchenko IA, Ponomaryova AA, Rykova EY, Laktionov PP. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities. Expert Rev. Mol. Diagn. 18(2), 133–145 (2018).
   PubMed Web of Science ®Google Scholar
• Aktar S, Baghaie H, Islam F, Gopalan V, Lam AK-Y. Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review. Otolaryngol. neck Surg. 168(5), 988–1005 (2023).
   PubMed Web of Science ®Google Scholar
• Sayal L, Hamadah O, Almasri A, Idrees M, Thomson P, Kujan O. Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role. J. oral Pathol. Med. 52(1), 29–36 (2023).
   PubMed Web of Science ®Google Scholar
• Chen B, Leung LL, Qu X, Chan JY-K. Extracellular Vesicles as Biomarkers in Head and Neck Squamous Cell Carcinoma: From Diagnosis to Disease-Free Survival. Cancers (Basel) 15(6),1826 (2023).
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature 431(7006), 350–355 (2004).
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39(16), 7223–7233 (2011).
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. U. S. A. 105(30), 10513–10518 (2008).
   PubMed Web of Science ®Google Scholar
• Lamichhane SR, Thachil T, Gee H, Milic N. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis. Dis. Markers 2019, 8632018 (2019).
   PubMed Web of Science ®Google Scholar
• Nowicka Z, Stawiski K, Tomasik B, Fendler W. Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis. Int. J. Mol. Sci. 20(19), 4799 (2019).
   PubMed Web of Science ®Google Scholar
• Galindo Torres BP, García Girón C, Alcaraz Ortega R, Saiz López P, Adiego Leza MI, Grijalba Uche MV. Knowledge and expectations about miRNAs as biomarkers in head and neck squamous cell cancers. Am. J. Otolaryngol. 44(2), 103771 (2022).
   PubMed Web of Science ®Google Scholar
• Racila E, Euhus D, Weiss AJ et al. Detection and characterization of carcinoma cells in the blood. Proc. Natl Acad. Sci. U. S. A. 95(8), 4589–4594 (1998).
   PubMed Web of Science ®Google Scholar
• Friedländer MR, Mackowiak SD, Li N, Chen W, Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 40(1), 37–52 (2012).
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26(1), 139–140 (2010).
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 48(D1), D127–D131 (2020).
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 16(5), 284–287 (2012).
   PubMed Web of Science ®Google Scholar
• Cohen EEW, Bell RB, Bifulco CB et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J. Immunother. Cancer. 7(1), 1–31 (2019).
   PubMed Web of Science ®Google Scholar
• Dilsiz N. Role of exosomes and exosomal microRNAs in cancer. Futur. Sci. OA. 6(4), FSO465 (2020).
   PubMed Web of Science ®Google Scholar
• Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. Int. J. Mol. Sci. 22(11), 5703 (2021).
   PubMed Web of Science ®Google Scholar
• Jeong H-J, Hong S-H, Park R-K, Shin T, An N-H, Kim H-M. Hypoxia-induced IL-6 production is associated with activation of MAP kinase, HIF-1, and NF-kappaB on HEI-OC1 cells. Hear. Res. 207(1–2), 59–67 (2005).
   PubMed Web of Science ®Google Scholar
• Niu J, Sun Y, Guo Q, Niu D, Liu B. Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma. Springerplus. 5(1), 1947 (2016).
   PubMedGoogle Scholar
• Feng S, Lu Y, Sun L et al. MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1. Ann. Transl. Med. 10(21), 1171 (2022).
   PubMed Web of Science ®Google Scholar
• Xi M, Cheng L, Hua W et al. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway. Eur. Rev. Med. Pharmacol. Sci. 23(3), 1002–1011 (2019).
   PubMed Web of Science ®Google Scholar
• Chen Z, Gong X, Cheng C, Fu Y, Wu W, Luo Z. Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis. Clin. Breast Cancer. 23(2), 143–154 (2023).
   PubMed Web of Science ®Google Scholar
• Wu Z, Lun P, Ji T et al. LncRNA SNHG25 Promotes Glioma Progression Through Activating MAPK Signaling. Mol. Neurobiol. 59(11), 6993–7005 (2022).
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang J-H, Wang H et al. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients. J. Cell. Physiol. 234(7), 11610–11619 (2019).
   PubMed Web of Science ®Google Scholar
• Panigrahi GK, Ramteke A, Birks D et al. Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer. Oncotarget. 9(17), 13894–13910 (2018).
   PubMedGoogle Scholar
• Xu X, Ban Y, Zhao Z, Pan Q, Zou J. MicroRNA-1298-3p inhibits proliferation and invasion of glioma cells by downregulating Nidogen-1. Aging (Albany. NY). 12(9), 7761–7773 (2020).
   PubMedGoogle Scholar
• Li K, Zhou M, Zhang Y. MicroRNA-1298-3p induces tumor-suppressive effects in human cervical cancer cells via post-transcriptional suppression of ONECUT2. Acta Biochim. Pol. 69(4), 737–743 (2022).
   PubMed Web of Science ®Google Scholar
• Pedersen NJ, Jensen DH, Lelkaitis G et al. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma. Oral Oncol. 83, 46–52 (2018).
   PubMed Web of Science ®Google Scholar
• Quintanilha JCF, Cursino MA, Borges JB et al. MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer. BMC Cancer. 21(1), 575 (2021).
   PubMed Web of Science ®Google Scholar
• Lu Z, He Q, Liang J et al. miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer. Mol. Ther. Nucleic Acids. 16, 471–480 (2019).
   PubMedGoogle Scholar
• Baber S, Bayat M, Mohamadnia A, Shamshiri A, Amini Shakib P, Bahrami N. Role of miR153 and miR455-5p Expression in Oral Squamous Cell Carcinoma Isolated from Plasma. Asian Pac. J. Cancer Prev. 22(1), 157–161 (2021).
   PubMedGoogle Scholar
• Dufourd T, Robil N, Mallet D et al. Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkers. Biol. methods Protoc. 4(1), bpz006 (2019).
   PubMedGoogle Scholar
• Summerer I, Niyazi M, Unger K et al. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat. Oncol. 8, 296 (2013).
   PubMed Web of Science ®Google Scholar
• Pasi F, Corbella F, Baio A et al. Radiation-induced circulating miRNA expression in blood of head and neck cancer patients. Radiat. Environ. Biophys. 59(2), 237–244 (2020).
   PubMed Web of Science ®Google Scholar
• Dharmawardana N, Ooi EH, Woods C, Hussey D. Circulating microRNAs in head and neck cancer: a scoping review of methods. Clin. Exp. Metastasis 36(3), 291–302 (2019).
   PubMed Web of Science ®Google Scholar